상세 보기

A randomized controlled, open label, adaptive phase III Trial to evaluate safety and efficacy of endoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment

Chen, L-T.;
Hitre, E.;
Lee, W-J.;
Bai, L-Y.;
Papai, Z.;
... Oh, S. C.;
외 5명

제목: A randomized controlled, open label, adaptive phase III Trial to evaluate safety and efficacy of endoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment

저자: Chen, L-T.; Hitre, E.; Lee, W-J.; Bai, L-Y.; Papai, Z.; Kang, S. Y.; Dvorkin, M.; Choi, H. J.; Oh, S. C.; Artru, P.; Bachet, J-B.

DOI: 10.1093/annonc/mdz247

발행일: 2019-10

학회명: 44th Congress of the European-Society-for-Medical-Oncology (ESMO)

개최지: Barcelona, SPAIN

개최국가: 영국

학회 개최일: 2019-09-27 ~ 2019-10-01

언어: ENG